LADENBURG THALMANN FINANCIAL SERVICES INC. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$3,000
-72.7%
29,763
-57.5%
0.00%
Q2 2019$11,000
+120.0%
70,057
+221.5%
0.00%
Q1 2019$5,000
+25.0%
21,794
+24.5%
0.00%
Q4 2018$4,000
-42.9%
17,500
+133.3%
0.00%
Q3 2018$7,0000.0%7,500
+66.7%
0.00%
Q2 2018$7,0000.0%4,5000.0%0.00%
Q1 2018$7,000
+40.0%
4,500
+80.0%
0.00%
Q4 2017$5,0002,5000.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders